Ashland Inc. Reports $16 Million Net Income and Revenue Increase for Q1 2026

Ashland Inc. reported a net income of $16 million, or $0.34 per diluted share, for the three months ended March 31, 2026, compared to $31 million, or $0.63 per diluted share, for the same period in 2025. The company’s revenue for the quarter increased slightly to $482 million from $479 million year-over-year, driven primarily by favorable foreign currency exchange rates, which offset declines in pricing and volume. For the six months ended March 31, 2026, Ashland's revenue decreased to $868 million from $884 million in the prior year, reflecting challenges in pricing and volume, as well as the impact of the divestiture of the Avoca business.

In terms of operational performance, Ashland's adjusted EBITDA for the three months ended March 31, 2026, was $98 million, down from $108 million in the same quarter of the previous year. The decline was attributed to softer pricing and operational disruptions, including delays in the startup of the Calvert City facility and adverse weather conditions. The company also reported a decrease in operating income to $39 million from $51 million year-over-year, with the Specialty Additives segment experiencing a significant operating loss of $7 million, compared to a profit of $7 million in the prior year.

Strategically, Ashland has been focusing on restructuring initiatives to enhance profitability and streamline operations. The company initiated a $30 million pre-tax restructuring plan aimed at offsetting the impacts of recent divestitures and optimizing its manufacturing network. This plan is expected to yield savings of $50 million to $55 million, although the realization of these benefits has been slower than anticipated due to productivity challenges at the Hopewell site. Additionally, Ashland has continued to implement portfolio optimization actions, which have had a mixed impact on sales and adjusted EBITDA.

As of March 31, 2026, Ashland's total assets were reported at $4.499 billion, down from $4.611 billion at the end of the previous fiscal year. The company’s cash and cash equivalents increased to $343 million from $215 million, reflecting improved cash flow from operations. Ashland's long-term debt decreased slightly to $1.374 billion from $1.384 billion. The company maintains a strong liquidity position with $939 million available, including cash and a revolving credit facility. Looking ahead, Ashland has updated its fiscal 2026 sales guidance to a range of $1.835 to $1.870 billion, with adjusted EBITDA expected between $385 million and $400 million, amid ongoing challenges and a mixed macroeconomic environment.